AFP and hepatocellular carcinoma: As shown in Fig. 3, there was a consistent trend toward higher recurrence risk in recipients with sarcopenia than in recipients without sarcopenia irrespective of the presence of other independent risk factors, indicating that there was no interaction effect of sarcopenia with alpha-fetoprotein or microvascular invasion on HCC recurrence and supporting the independence of sarcopenia.